Free Trial

DENTSPLY SIRONA (XRAY) Competitors

DENTSPLY SIRONA logo
$14.08 +0.16 (+1.11%)
As of 02:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

XRAY vs. MMSI, ICUI, HAE, QDEL, NEOG, STAA, CERS, OSUR, ANIK, and UTMD

Should you be buying DENTSPLY SIRONA stock or one of its competitors? The main competitors of DENTSPLY SIRONA include Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry.

DENTSPLY SIRONA vs.

Merit Medical Systems (NASDAQ:MMSI) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, community ranking, earnings, profitability, valuation and analyst recommendations.

Merit Medical Systems has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Comparatively, DENTSPLY SIRONA has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500.

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 3.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Merit Medical Systems has a net margin of 9.05% compared to DENTSPLY SIRONA's net margin of -10.59%. Merit Medical Systems' return on equity of 15.61% beat DENTSPLY SIRONA's return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.05% 15.61% 8.38%
DENTSPLY SIRONA -10.59%12.62%5.45%

DENTSPLY SIRONA received 20 more outperform votes than Merit Medical Systems when rated by MarketBeat users. However, 70.22% of users gave Merit Medical Systems an outperform vote while only 60.82% of users gave DENTSPLY SIRONA an outperform vote.

CompanyUnderperformOutperform
Merit Medical SystemsOutperform Votes
455
70.22%
Underperform Votes
193
29.78%
DENTSPLY SIRONAOutperform Votes
475
60.82%
Underperform Votes
306
39.18%

Merit Medical Systems has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.36B4.06$94.41M$2.0445.69
DENTSPLY SIRONA$3.79B0.73-$132M-$4.55-3.06

In the previous week, Merit Medical Systems had 14 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 32 mentions for Merit Medical Systems and 18 mentions for DENTSPLY SIRONA. DENTSPLY SIRONA's average media sentiment score of 0.98 beat Merit Medical Systems' score of 0.71 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
14 Very Positive mention(s)
5 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
DENTSPLY SIRONA
11 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems presently has a consensus price target of $107.78, indicating a potential upside of 15.64%. DENTSPLY SIRONA has a consensus price target of $21.25, indicating a potential upside of 52.55%. Given DENTSPLY SIRONA's higher probable upside, analysts plainly believe DENTSPLY SIRONA is more favorable than Merit Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.00
DENTSPLY SIRONA
0 Sell rating(s)
12 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14

Summary

Merit Medical Systems beats DENTSPLY SIRONA on 14 of the 19 factors compared between the two stocks.

Get DENTSPLY SIRONA News Delivered to You Automatically

Sign up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XRAY vs. The Competition

MetricDENTSPLY SIRONADental equipment & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$2.78B$4.06B$5.54B$7.93B
Dividend Yield4.59%2.43%5.09%4.23%
P/E Ratio-6.7353.1522.5718.54
Price / Sales0.731.46399.89103.29
Price / Cash3.926.5738.1834.62
Price / Book0.900.616.774.25
Net Income-$132M-$153.72M$3.22B$248.18M
7 Day Performance1.31%-0.19%1.07%0.91%
1 Month Performance-6.32%-6.21%2.46%2.58%
1 Year Performance-50.92%142.29%15.74%4.02%

DENTSPLY SIRONA Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XRAY
DENTSPLY SIRONA
4.9011 of 5 stars
$14.07
+1.0%
$21.25
+51.1%
-53.8%$2.80B$3.79B-6.7915,000Upcoming Earnings
Analyst Forecast
Gap Up
MMSI
Merit Medical Systems
3.9836 of 5 stars
$95.44
+0.9%
$109.00
+14.2%
+21.6%$5.64B$1.36B46.786,850Short Interest ↑
ICUI
ICU Medical
3.8658 of 5 stars
$135.90
+0.2%
$162.67
+19.7%
+39.4%$3.34B$2.38B-29.7414,500Upcoming Earnings
Analyst Upgrade
HAE
Haemonetics
4.6259 of 5 stars
$62.55
+0.1%
$101.22
+61.8%
-31.6%$3.14B$1.37B24.632,820Upcoming Earnings
News Coverage
Positive News
QDEL
QuidelOrtho
4.548 of 5 stars
$28.96
+3.1%
$46.83
+61.7%
-29.7%$1.95B$2.78B-0.967,000Upcoming Earnings
Analyst Revision
News Coverage
Positive News
Gap Up
NEOG
Neogen
3.8135 of 5 stars
$5.14
-0.4%
$9.00
+75.1%
-58.0%$1.12B$906.00M-2.352,110Analyst Revision
Positive News
STAA
STAAR Surgical
4.32 of 5 stars
$18.16
+0.7%
$24.25
+33.5%
-59.0%$895.74M$313.90M-44.29960Upcoming Earnings
Gap Up
CERS
Cerus
2.0691 of 5 stars
$1.34
-0.7%
$3.50
+161.2%
-24.4%$256.15M$180.27M-12.18290Earnings Report
News Coverage
OSUR
OraSure Technologies
4.5716 of 5 stars
$3.04
+1.7%
$5.50
+80.9%
-44.8%$227.39M$185.83M20.27840Upcoming Earnings
ANIK
Anika Therapeutics
4.0443 of 5 stars
$14.51
+0.6%
$21.67
+49.3%
-45.4%$205.69M$119.91M-2.18300Upcoming Earnings
Positive News
UTMD
Utah Medical Products
2.5885 of 5 stars
$52.21
-0.3%
N/A-23.1%$171.35M$40.90M13.22180Earnings Report
News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:XRAY) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners